Redefining ADHD: A New Approach & A Shift of Paradigm in ADHD Therapeutics

PARIS and NEW YORK, Dec. 23, 2014 /PRNewswire/ —¬†NeuroLifeSciences announced today groundbreaking data from its open-label pilot study of mazindol in children with attention deficit/hyperactivity disorder …

from Content Keyword RSS http://ift.tt/13AQhGk http://ift.tt/eA8V8J

Advertisements

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s